AVP and coronary artery disorder: Using data from 2700 patients with symptomatic coronary artery disease who either presented with suspected ACS to the ED or for elective coronary angiography, von Haehling et al. [30] reported that the predictive performance of copeptin was independent of other clinical variables or cardiovascular risk factors, and superior to that of troponin I and other cardiac biomarkers (p < 0.0001).